Evidence map›Paper›PMID 35737458›Full record

ArticleJCI insight2022

Monocyte proinflammatory phenotypic control by ephrin type A receptor 4 mediates neural tissue damage.

Elizabeth A Kowalski, Eman Soliman, Colin Kelly, Erwin Kristobal Gudenschwager Basso, John Leonard, Kevin J Pridham, Jing Ju, Alison Cash, Amanda Hazy, Caroline de Jager and 8 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Lipidation and PEGylation Strategies to Prolong theEuropean journal of medicinal chemistry · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Elizabeth A KowalskiDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Eman SolimanDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Colin KellyDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Erwin Kristobal Gudenschwager BassoDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
John LeonardDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Kevin J PridhamDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Jing JuDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Alison CashDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Amanda HazyDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Caroline de JagerDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Alexandra M KalossDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Hanzhang DingTranslational Biology Medicine and Health Graduate Program, Virginia Tech, Blacksburg, Virginia, USA.
Raymundo D HernandezTranslational Biology Medicine and Health Graduate Program, Virginia Tech, Blacksburg, Virginia, USA.
Gabe ColemanSchool of Neuroscience, and.
Xia WangDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Michelle L OlsenSchool of Neuroscience, and.
Alicia M PickrellSchool of Neuroscience, and.
Michelle H TheusDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia, USA.
Virginia Tech · USZagazig University · EG

Funding

Divergent age-dependent peripheral innate immune response following TBIR01NS119540 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI THEUS, MICHELLE LEE · 2021 to 2025
$2.6M
Novel mechanisms suppressing the pro-resolving phenotype of peripheral innate immunity following traumatic brain injuryR01NS121103 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI THEUS, MICHELLE LEE · 2021 to 2025
$2.5M
NINDS NIH HHS R01 NS119540NINDS NIH HHS R01 NS121103
6 · The paper itself

Abstract

Circulating monocytes have emerged as key regulators of the neuroinflammatory milieu in a number of neuropathological disorders. Ephrin type A receptor 4 (Epha4) receptor tyrosine kinase, a prominent axon guidance molecule, has recently been implicated in the regulation of neuroinflammation. Using a mouse model of brain injury and a GFP BM chimeric approach, we found neuroprotection and a lack of significant motor deficits marked by reduced monocyte/macrophage cortical infiltration and an increased number of arginase-1+ cells in the absence of BM-derived Epha4. This was accompanied by a shift in monocyte gene profile from pro- to antiinflammatory that included increased Tek (Tie2 receptor) expression. Inhibition of Tie2 attenuated enhanced expression of M2-like genes in cultured Epha4-null monocytes/macrophages. In Epha4-BM-deficient mice, cortical-isolated GFP+ monocytes/macrophages displayed a phenotypic shift from a classical to an intermediate subtype, which displayed reduced Ly6chi concomitant with increased Ly6clo- and Tie2-expressing populations. Furthermore, clodronate liposome-mediated monocyte depletion mimicked these effects in WT mice but resulted in attenuation of phenotype in Epha4-BM-deficient mice. This demonstrates that monocyte polarization not overall recruitment dictates neural tissue damage. Thus, coordination of monocyte proinflammatory phenotypic state by Epha4 is a key regulatory step mediating brain injury.

Indexed as

Brain InjuriesMonocytesAnimalsEphrinsHumansMicePhenotypeReceptor, EphB2EphrinsReceptor, EphB2Neurological disordersNeuroscience

Identifiers

PMID35737458
PMCPMC9462496
OpenAlexW4283374965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.